Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2019-03-01

First treatment for rare disease characterised by high levels of triglycerides in blood

View source ↗

Summary

The EMA announces the first treatment for a rare disease characterized by very high triglyceride levels in the blood, addressing a previously unmet medical need…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications